The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

Researchers are evaluating whether biologic therapies for severe asthma reduce the risk for osteoarthritis progression in ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today confirmed that DOMA Perpetual ...

Lipocartilage has been identified as a novel adipose-related cartilage subtype generated by lipochondrocytes, which produce intracellular lipid vacuoles that provide structural rigidity to the outer ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...